Multilayer Structures in Lipid Monolayer Films Containing Surfactant Protein C: Effects of Cholesterol and POPE

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2005 Jan 18

PMID 15653721

Citations 15

Authors

Stefan Malcharek

Andreas Hinz

Lutz Hilterhaus

Hans-Joachim Galla

Affiliations

Soon will be listed here.

Abstract

The influence of cholesterol and POPE on lung surfactant model systems consisting of DPPC/DPPG (80:20) and DPPC/DPPG/surfactant protein C (80:20:0.4) has been investigated. Cholesterol leads to a condensation of the monolayers, whereas the isotherms of model lung surfactant films containing POPE exhibit a slight expansion combined with an increased compressibility at medium surface pressure (10-30 mN/m). An increasing amount of liquid-expanded domains can be visualized by means of fluorescence light microscopy in lung surfactant monolayers after addition of either cholesterol or POPE. At surface pressures of 50 mN/m, protrusions are formed which differ in size and shape as a function of the content of cholesterol or POPE, but only if SP-C is present. Low amounts of cholesterol (10 mol %) lead to an increasing number of protrusions, which also grow in size. This is interpreted as a stabilizing effect of cholesterol on bilayers formed underneath the monolayer. Extreme amounts of cholesterol (30 mol %), however, cause an increased monolayer rigidity, thus preventing reversible multilayer formation. In contrast, POPE, as a nonbilayer lipid thought to stabilize the edges of protrusions, leads to more narrow protrusions. The lateral extension of the protrusions is thereby more influenced than their height.

Citing Articles

Lung surfactant as a biophysical assay for inhalation toxicology.

Liu J, Sayes C Curr Res Toxicol. 2023; 4:100101.

PMID: 36687216 PMC: 9849875. DOI: 10.1016/j.crtox.2022.100101.

Physical properties of phospholipids and integral proteins and their biofunctional roles in pulmonary surfactant from molecular dynamics simulation.

Hadrioui N, Lemaalem M, Derouiche A, Ridouane H RSC Adv. 2022; 10(14):8568-8579.

PMID: 35497816 PMC: 9049990. DOI: 10.1039/d0ra00077a.

Structural Changes in Films of Pulmonary Surfactant Induced by Surfactant Vesicles.

Andreev K, Martynowycz M, Kuzmenko I, Bu W, Hall S, Gidalevitz D Langmuir. 2020; 36(45):13439-13447.

PMID: 33080138 PMC: 8754419. DOI: 10.1021/acs.langmuir.0c01813.

Alveolar lipids in pulmonary disease. A review.

Agudelo C, Samaha G, Garcia-Arcos I Lipids Health Dis. 2020; 19(1):122.

PMID: 32493486 PMC: 7268969. DOI: 10.1186/s12944-020-01278-8.

Anchoring dipalmitoyl phosphoethanolamine to nanoparticles boosts cellular uptake and fluorine-19 magnetic resonance signal.

Waiczies S, Lepore S, Sydow K, Drechsler S, Ku M, Martin C Sci Rep. 2015; 5:8427.

PMID: 25673047 PMC: 5389132. DOI: 10.1038/srep08427.

References

SAULNIER , Foussard , Boury , Proust . Structural Properties of Asymmetric Mixed-Chain Phosphatidylethanolamine Films. J Colloid Interface Sci. 1999; 218(1):40-46. DOI: 10.1006/jcis.1999.6409. View

Daniels C, Barr H, Power J, Nicholas T . Body temperature alters the lipid composition of pulmonary surfactant in the lizard Ctenophorus nuchalis. Exp Lung Res. 1990; 16(5):435-49. DOI: 10.3109/01902149009068819. View

Yuan C, Johnston L . Distribution of ganglioside GM1 in L-alpha-dipalmitoylphosphatidylcholine/cholesterol monolayers: a model for lipid rafts. Biophys J. 2000; 79(5):2768-81. PMC: 1301158. DOI: 10.1016/S0006-3495(00)76516-7. View

Virtanen J, Ruonala M, Vauhkonen M, Somerharju P . Lateral organization of liquid-crystalline cholesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry. 1995; 34(36):11568-81. DOI: 10.1021/bi00036a033. View

Plasencia I, Rivas L, Keough K, Marsh D, Perez-Gil J . The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers. Biochem J. 2003; 377(Pt 1):183-93. PMC: 1223849. DOI: 10.1042/BJ20030815. View

Krol S, ROSS M, Sieber M, Kunneke S, Galla H, Janshoff A . Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B. Biophys J. 2000; 79(2):904-18. PMC: 1300988. DOI: 10.1016/S0006-3495(00)76346-6. View

Yu S, Possmayer F . Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films. J Lipid Res. 1996; 37(6):1278-88. View

Taneva S, Keough K . Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface. Biochemistry. 1997; 36(4):912-22. DOI: 10.1021/bi9623542. View

Kahn M, Anderson G, Anyan W, Hall S . Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol. 1995; 269(5 Pt 1):L567-73. DOI: 10.1152/ajplung.1995.269.5.L567. View

10.

Yu S, Possmayer F . Interaction of pulmonary surfactant protein A with dipalmitoylphosphatidylcholine and cholesterol at the air/water interface. J Lipid Res. 1998; 39(3):555-68. View

11.

Somerharju P, Virtanen J, Eklund K, Vainio P, Kinnunen P . 1-Palmitoyl-2-pyrenedecanoyl glycerophospholipids as membrane probes: evidence for regular distribution in liquid-crystalline phosphatidylcholine bilayers. Biochemistry. 1985; 24(11):2773-81. DOI: 10.1021/bi00332a027. View

12.

Robertson B, Halliday H . Principles of surfactant replacement. Biochim Biophys Acta. 1998; 1408(2-3):346-61. DOI: 10.1016/s0925-4439(98)00080-5. View

13.

Diemel R, Snel M, van Golde L, Putz G, Haagsman H, Batenburg J . Effects of cholesterol on surface activity and surface topography of spread surfactant films. Biochemistry. 2002; 41(50):15007-16. DOI: 10.1021/bi0256532. View

14.

Schurch S, Qanbar R, Bachofen H, Possmayer F . The surface-associated surfactant reservoir in the alveolar lining. Biol Neonate. 1995; 67 Suppl 1:61-76. DOI: 10.1159/000244207. View

15.

von Nahmen A, Post A, Galla H, Sieber M . The phase behavior of lipid monolayers containing pulmonary surfactant protein C studied by fluorescence light microscopy. Eur Biophys J. 1997; 26(5):359-69. DOI: 10.1007/s002490050090. View

16.

Nogee L, de Mello D, Dehner L, Colten H . Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med. 1993; 328(6):406-10. DOI: 10.1056/NEJM199302113280606. View

17.

Vandenbussche G, Clercx A, Curstedt T, Johansson J, Jornvall H, Ruysschaert J . Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur J Biochem. 1992; 203(1-2):201-9. DOI: 10.1111/j.1432-1033.1992.tb19848.x. View

18.

Haagsman H, Hawgood S, Sargeant T, Buckley D, WHITE R, Drickamer K . The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem. 1987; 262(29):13877-80. View

19.

Vist M, Davis J . Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry. Biochemistry. 1990; 29(2):451-64. DOI: 10.1021/bi00454a021. View

20.

Glasser S, Detmer E, Ikegami M, Na C, Stahlman M, Whitsett J . Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem. 2003; 278(16):14291-8. DOI: 10.1074/jbc.M210909200. View